Founded in 2016, Surgical Innovation Associates manufactures an absorbable mesh for plastic and reconstructive surgery, focusing on implant-based breast reconstruction for mastectomy patients.
“Integra’s global reach and commercial strength will help enable us to achieve our joint mission to improve outcomes in women’s health,” said Josh Vose, MD, CEO of Surgical Innovation Associates, in a Dec. 1 company news release.
Integra will pay $50 million at closing and up to $90 million more depending on certain revenue and regulatory achievements.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
